Davide Croci

Davide Croci is a Biomarker Scientist at Novigenix SA since April 2023, where developments in clinical biomarker discovery strategies in biofluids are spearheaded for drug development in immuno-oncology. Prior experience includes a position as a Research Associate and PhD Student at the University of Lausanne from October 2016 to July 2022, focusing on therapeutic antibodies in neurological tumor treatment and the development of multi-imaging methods. Additional roles include a Marketing Consultant internship at SEED Biosciences, a graduate role at Novartis Institutes for BioMedical Research, and a lab technician position at the University of Zurich. Educational credentials comprise a PhD in Life Science from the University of Lausanne, and both a Master's and Bachelor's degree in Cell Biology and Biology from ETH Zürich, respectively.